Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-30

Clinical Trial Update: Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial compares 4 mg vs 8 mg submucosal dexamethasone for managing postoperative pain after dental implant surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Oman Ministry of Health | Conditions: Postoperative Pain | Phase 3 | Status: RECRUITING